Literature DB >> 32147675

A pirfenidone loaded spray dressing based on lyotropic liquid crystals for deep partial thickness burn treatment: healing promotion and scar prophylaxis.

Jintian Chen1, Hui Wang1, Liling Mei1, Bei Wang1, Ying Huang2, Guilan Quan2, Chao Lu1, Tingting Peng2, Xin Pan1, Chuanbin Wu3.   

Abstract

A deep partial thickness (DPT) burn injury refers to burn damage involving the epidermis and major dermis, whose prognosis depends greatly on wound management. Lack of effective management can lead to an elongated healing process and aggravated scar formation, which can severely disturb patients, both physically and mentally. A dressing with good water absorption and moderate mechanical properties is crucial for healing promotion, and the prevention of scar formation is highly desirable. In this project, a hyaluronic acid combined lyotropic liquid crystal based spray dressing (HLCSD) loaded with the anti-fibrotic drug pirfenidone (PFD) has been designed. HLCSD is expected to achieve the goals of both wound healing promotion and scar prophylaxis. Its water absorption capacity, mechanical properties, drug release behavior and phase transition are fully evaluated. HLCSD possesses low viscosity for spray administration and high levels of water absorption for exudate absorption. An in situ gel composed of self-assembled lattice nanostructures provides excellent mechanical protection to promote the healing process and steady PFD release to exert a scar prophylaxis effect. The benefit of HLCSD on the wound healing rate is verified in vivo. In the DPT burn wound model we established, HLCSD also exhibits excellent healing promotion effects, and PFD-loaded HLCSD shows scar prophylaxis effects and displays an ideal prognosis, with skin as smooth as healthy skin. The healing promotion of HLCSD is considered to be related to the alleviation of inflammation, with an obviously shortened inflammation phase, with contributions from water management, mechanical protection and anti-inflammation by HLCSD. The scar prophylaxis of PFD-loaded HLCSD is proven to be related to the regulation of collagen synthesis and degradation, involving key cytokines like TGF-β and MMP-1. Taken together, the PFD-loaded HLCSD with healing promotion and scar prophylaxis offers significant promise as a spray dressing for DPT burn injuries.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32147675     DOI: 10.1039/c9tb02929j

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  5 in total

1.  Improving Water-Absorption and Mechanical Strength: Lyotropic Liquid Crystalline-Based Spray Dressings as a Candidate Wound Management System.

Authors:  Chen Wang; Jingtian Chen; Xiao Yue; Xiao Xia; Ziqiang Zhou; Guanlin Wang; Xuejuan Zhang; Ping Hu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2022-02-01       Impact factor: 3.246

2.  Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application.

Authors:  Antonia Mancuso; Eleonora Cianflone; Maria Chiara Cristiano; Nadia Salerno; Martine Tarsitano; Fabiola Marino; Claudia Molinaro; Massimo Fresta; Daniele Torella; Donatella Paolino
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

3.  New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring?

Authors:  Patricia Liana Cristodor; Alexandru Nechifor; Silvia Fotea; Alin Codrut Nicolescu; Thomas Nadasdy; Yousef Bahloul; Alin Laurentiu Tatu
Journal:  Int J Gen Med       Date:  2022-09-12

4.  Asiaticoside-laden silk nanofiber hydrogels to regulate inflammation and angiogenesis for scarless skin regeneration.

Authors:  Lutong Liu; Zhaozhao Ding; Yan Yang; Zhen Zhang; Qiang Lu; David L Kaplan
Journal:  Biomater Sci       Date:  2021-07-27       Impact factor: 7.590

5.  Biphasic Effect of Pirfenidone on Angiogenesis.

Authors:  Donghao Gan; Wenxiang Cheng; Liqing Ke; Antonia RuJia Sun; Qingyun Jia; Jianhai Chen; Zhanwang Xu; Juan Xu; Peng Zhang
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.